The in vivo modulatory effects of an anterior-chamber microenvironment on uveal melanoma

British Journal of Ophthalmology

Volumn 93, Issue 4, 2009, Pages 535-540

  Mudhar, H S ^a   Saunders, E ^a   Rundle, P ^a   Rennie, I G ^b   Sisley, K ^b  

^a ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CYCLE PROTEIN; CYCLIN D1; PARAFFIN; PROTEIN P27;

ADULT; AGED; ANTERIOR EYE CHAMBER; AQUEOUS HUMOR; ARTICLE; CHROMOSOME 3; CHROMOSOME 8; CILIARY BODY MELANOMA; CLINICAL ARTICLE; CLINICAL FEATURE; DISEASE COURSE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; IRIS MELANOMA; MALE; METASTASIS; MICROSCOPY; PRIORITY JOURNAL; UVEA MELANOMA;

AGED; AGED, 80 AND OVER; ANTERIOR CHAMBER; CHROMOSOMES, HUMAN, PAIR 3; CHROMOSOMES, HUMAN, PAIR 8; CILIARY BODY; CYCLIN D1; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; IRIS; MALE; MELANOMA; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; PROLIFERATING CELL NUCLEAR ANTIGEN; TISSUE FIXATION; UVEAL NEOPLASMS;

EID: 64849099414     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjo.2008.147314     Document Type: Article

References (24)

1. Shields CL, Shields JA, Materin M, et al. Iris melanoma: risk factors in 169 consecutive cases. Ophthalmology 2001;108:172- 8.
2. Sisley K, Brand C, Parsons MA, et al. Cytogenetics of iris melanomas; disparity with other uveal melanomas. Cancer Genet Cytogenet 1998;101:128-33.
3. Canovas, D, Rennie IG, Nichols CE, et al. Local environmental influences on uveal melanoma: The vitreous humour promotes uveal melanoma invasion, whilst the aqueous can be inhibitory. Cancer 2008;112:1787-94.
4. Patel KA, Edmondson ND, Talbot F, et al. Prediction of prognosis in patients with uveal melanoma using fluorescence in situ hybridization. Br J Ophthalmol 2001;85:1440-4.
5. Damato B, Duke C, Coupland SE, et al. Cytogenetics of uveal melanoma: a 7 year clinical experience. Ophthalmology 2007;114:1925-31.
6. Folberg R, Pe'er J, Gruman LM, et al. The morphologic characteristics of tumour blood vessels as a marker of tumour progression in primary human uveal melanoma: a matched case-control study. Hum Pathol 1992;23:1298-305.
7. Folberg R, Rummelt V, Parys-Van Ginderdeuren R, et al. The prognostic value of tumor blood vessel morphology in primary uveal melanoma. Ophthalmology 1993;100:1389-98.
8. Huang S, Chen CS, Ingber DE. Control of cyclin D1, p27 (kip 1), and cell cycle progression in human capillary endothelial cells by cell shape and cytoskeletal tension. Mol Biol Cell 1998;9:3179-93.
9. Nagaki M, Sugiyama A, Naiki T, et al. Control of cyclins, cyclin-dependent kinase inhibitors, p21 and p27, and cell cycle progression in rat hepatocytes by extracellular matrix. J Hepatol 2000;32:488-96.
10. Folberg R, Arbieva Z, Moses J, et al. Tumour cell plasticity in uveal melanoma microenvironment directed dampening of the invasive and metastatic genotype and phenotype accompanies the generation of vasculogenic mimicry patterns. Am J Pathol 2006;169:1376-89.
11. Woodward JK, Elshaw SR, Murray AK, et al. Stimulation and inhibition of uveal melanoma invasion by HGF, GRO, IL-1alpha and TGF-beta. Invest Ophthalmol Vis Sci 2002;43:3144-52.
12. Hu DIM, McCormick SA, Lin AY, et al. TGF-beta 2 inhibitis growth of uveal melanocytes at physiological concentrations. Exp Eye Res 1998;67:143-50.
13. Myatt N, Aristodemou P, Neale MH, et al. Abnormalities of the transforming growth factor-beta pathway in ocular melanoma. J Pathol 2000;192:511-18.
14. Yamada H, Obata H, Kaji Y, et al. Expression of transforming growth factor-beta superfamily receptors in rat eyes. Acta Ophthalmol Scand 1999;77:151-6.
15. Koff A, Ohtsuki M, Polyak K, et al. Negative regulation of G1 in mammalian cells: Inhibition of cyclin E-dependent kinase by TGF-p. Science 1993;260:536-9.
16. Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest. Genes Dev 1994;8:9-22.
17. Slingerland JM, Hengst L, Pan CH, et al. A novel inhibitor of cyclin-Cdk activity detected in transforming growth factor p-arrested epithelial cells. Mol Cell Biol 1994;14:3683-94.
18. Huang LW, Chao SL, Hwang JL, et al. Down regulation pf p27 is associated with malignant transformation and aggressive phenotype of cervical neoplasms. Gynecologic Oncology 2002;85:524-8.
19. Ashwandner O, Bruch HP, Broil R. p21, p27. cyclin D1 and p53 in rectal cancer: immunohistology with prognostic significance? Int J Colorectal Dis 2002;17:11-19.
20. Migita T, Oda Y, Naito S, et al. Low expression of p27 (Kip1) is associated with tumour size and poor prognosis in patients with renal cell carcinoma. Cancer 2002;94:973-9.
21. Wilkens L, Gerr H, Gadzicki D, et al. Standardised fluorescence in situ hybridization in cytological and histological specimens. Virch Arch 2005;447:586-92.
22. Beerenwinkel N, Antal T, Dingli D, et al. Genetic progression and the waiting time to cancer. PLOS Comput Biol 2007;3:2230-45.
23. Maat W, Jordanova ES, van Zelderen-Bhola SL, et al. The heterogeneous distribution of monosomy 3 in uveal melanomas: implications for prognostication based on fineneedle aspiration biopsies. Arch Pathol Lab Med 2007;131:91-6.b
24. Mensink HW, Vaarwater J, Killic E, et al. Chromosome 3 intra-tumour heterogeneity in uveal melanoma. Invest Ophthalmol Vis Sci. Published Online First: 29 September 2008.